Skip to main content
logo
Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.150
-0.040 (-3.36%)
Aug 28, 2026, 3:28 PM EDT - Market open

Milestone Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.341.55-1515
Revenue Growth
----80.00%-66.67%-
Gross Profit
2.31.55-1515
Selling, General & Admin
64.4645.5827.7531.0524.8119.4
Research & Development
16.2218.1114.3631.0539.8338.67
Operating Expenses
80.6863.6942.162.164.6458.07
Operating Income
-78.38-62.14-42.1-61.1-59.64-43.07
Interest Expense
-10.81-3.84-3.58-2.55--
Interest & Investment Income
5.182.924.163.971.250.22
Pretax Income
-84.01-63.06-41.52-59.69-58.39-42.85
Net Income
-84.01-63.06-41.52-59.69-58.39-42.85
Net Income to Common
-84.01-63.06-41.52-59.69-58.39-42.85
Net Income Growth
------
Shares Outstanding (Basic)
1188462434242
Shares Outstanding (Diluted)
1188462434242
Shares Change
77.94%34.84%44.82%1.19%1.47%42.56%
EPS (Basic)
-0.71-0.75-0.67-1.39-1.38-1.02
EPS (Diluted)
-0.71-0.75-0.67-1.39-1.38-1.02
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-61.65-49.34-28.88-46.54-52.74-33.22
Free Cash Flow Per Share
-0.52-0.59-0.46-1.08-1.24-0.79
Gross Margin
98.04%100.00%-100.00%100.00%100.00%
Operating Margin
-3345.24%-4019.40%--6109.80%-1192.84%-287.15%
Profit Margin
-3585.62%-4078.78%--5968.50%-1167.76%-285.69%
Free Cash Flow Margin
-2631.07%-3191.66%--4653.60%-1054.82%-221.49%
EBITDA
-78.21-62.03-42-61.01-59.55-42.98
EBITDA Margin
------286.53%
D&A For EBITDA
0.170.110.110.090.090.09
EBIT
-78.38-62.14-42.1-61.1-59.64-43.07
EBIT Margin
------287.15%
SEC Filings: 10-K · 10-Q